Masimo Corporation (MASI) 52.00 $MASI DENTSPLY (XRAY)

New Post Public Reply Private Reply Replies (0) Message Board

Jun 10, 2016 at 2:18 PM

Masimo Corporation (MASI) 52.00 $MASI

DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 6:02AM CDT
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $64.59 on Jun 9.
IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), EXAC: 25.32 (+0.02), XRAY: 63.54 (-0.89)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 3:37AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations.
IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), TROV: 4.33 (-0.55), EXAC: 25.32 (+0.02)

Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), VAR: 84.76 (-0.81), CRY: 11.92 (-0.06)

Masimo Announces Full Market Release of Next Generation SpHb(R) Spot Check Pronto(R)
BusinessWire - Wed Jun 08, 7:06AM CDT
Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto(R) Pulse CO-Oximeter(R) with Next Generation SpHb(R) Spot Check technology. Next Generation Pronto features rainbow SET(TM) technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).
MASI: 52.00 (-0.42)

Masimo Has Returned 31.9% Since SmarTrend Recommendation (MASI)
Comtex SmarTrend(R) - Wed Jun 08, 1:02AM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 3 months, Masimo has returned 31.93% as of today's recent price of $51.57.
MASI: 52.00 (-0.42)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:39AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations in the urine of patients with non-small cell lung cancer (NSCLC).
IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), TROV: 4.33 (-0.55), EXAC: 25.32 (+0.02)

AMN Healthcare Buys Peak Health Solutions, Boosts Portfolio
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:01AM CDT
AMN Healthcare Services Inc. (AHS) continues to expand its product offerings through acquisitions.
AIRM: 36.46 (-0.64), IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), AHS: 39.68 (-1.30)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.26 (-0.45), MASI: 52.00 (-0.42), EXAC: 25.32 (+0.02), CRY: 11.92 (-0.06)

The Cooper Companies (COO) Beats Q2 Earnings, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:40AM CDT
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.05 in the second quarter of 2016, beating the Zacks Consensus Estimate by 13 cents.
HYH: 32.62 (-0.76), MASI: 52.00 (-0.42), CRY: 11.92 (-0.06), COO: 162.74 (-2.46)

Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 52.00 (-0.42), EW: 101.16 (-1.32), LMNX: 20.39 (-0.41), CRY: 11.92 (-0.06)

One of India's Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET(R) Technology
BusinessWire - Thu Jun 02, 7:03AM CDT
Masimo (NASDAQ: MASI) announced today that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET(R) (Signal Extraction Technology) pulse oximetry at all locations. Motherhood Hospitals will also be screening for Critical Congenital Heart Disease (CCHD) using Masimo's technology.
MASI: 52.00 (-0.42)

Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 52.00 (-0.42), INGN: 49.38 (-0.85), EXAC: 25.32 (+0.02), CRY: 11.92 (-0.06)

26.9% Return Seen to Date on SmarTrend Masimo Call (MASI)
Comtex SmarTrend(R) - Tue May 31, 1:33PM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 3 months, Masimo has returned 26.89% as of today's recent price of $49.60.
MASI: 52.00 (-0.42)

Masimo to Showcase Next Generation SedLine(R) Brain Function Monitor at 2016 Euroanaesthesia Congress
BusinessWire - Thu May 26, 7:55AM CDT
Masimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine(R) Brain Function Monitoring technology at the European Society of Anaesthesiology's (ESA) 2016 Euroanaesthesia Congress in London, England.
MASI: 52.00 (-0.42)

Cynosure (CYNO) Up on FDA Approval for New 1064nm LDS
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:44AM CDT
Cynosure Inc. (CYNO) recently announced the receipt of FDA approval for marketing a new Laser Delivery System (LDS) for PicoSure.
IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), CYNO: 51.27 (-0.81), EXAC: 25.32 (+0.02)

Baxter Unveils THERANOVA Dialyser at ERA-EDTA Congress
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:42AM CDT
Baxter International Inc. (BAX) recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers.
SRDX: 23.43 (+0.13), IRMD: 21.34 (-0.14), MASI: 52.00 (-0.42), BAX: 44.40 (-0.35)

HealthEquity (HQY): Strong Buy on Impressive Q4 Earnings
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:45AM CDT
On May 24, Zacks Investment Research raised HealthEquity Inc. (HQY) to a Zacks Rank #1 (Strong Buy).
AIRM: 36.46 (-0.64), MASI: 52.00 (-0.42), HQY: 28.80 (+0.60), AHS: 39.68 (-1.30)

The Zacks Analyst Blog Highlights: Cable ONE, Amphastar Pharmaceuticals, Shutterstock, Masimo and American Public Education
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:30AM CDT
The Zacks Analyst Blog Highlights: Cable ONE, Amphastar Pharmaceuticals, Shutterstock, Masimo and American Public Education
APEI: 27.13 (-0.55), CABO: 495.00 (-5.68), MASI: 52.00 (-0.42), SSTK: 42.08 (-1.35), AMPH: 16.16 (-0.27)

Baxter (BAX) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:22AM CDT
On May 20, Zacks Investment Research raised Baxter International Inc. (BAX) to a Zacks Rank #1 (Strong Buy).
SRDX: 23.43 (+0.13), MASI: 52.00 (-0.42), BAX: 44.40 (-0.35), EW: 101.16 (-1.32)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Docs Spotlight Psychiatry on World Mental Health Day

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

Retail Trading Platforms Report Record Growth in 2026

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

CenterPoint Deploys Crews for Hurricane Aid Relief

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...

AI in Music: CITY JAM Focuses on Human Creativity

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

AI Revenue Missteps Shake Semiconductor Stocks

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...